DIN 02381397 — EDARBI 80 MG
EDARBI is a tablet of Azilsartan Medoxomil marketed by BAUSCH HEALTH, CANADA INC.. The full Azilsartan Medoxomil monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02381397
- Brand name
- EDARBI
- Active ingredient
- Azilsartan Medoxomil
- Strength
- 80 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- BAUSCH HEALTH, CANADA INC.
- Health Canada status
- MARKETED
- Drug class
- Angiotensin II AT1 receptor blocker (ARB)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Azilsartan Medoxomil products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02547015 | AURO-AZILSARTAN MEDOXOMIL | 40 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02547023 | AURO-AZILSARTAN MEDOXOMIL | 80 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02381389 | EDARBI | 40 MG | TABLET | BAUSCH HEALTH, CANADA INC. | MARKETED |